- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Galectin Therapeutics Inc (GALT)
Assess today's live Galectin Therapeutics Inc (GALT) share price, performance and insights using our live NASDAQ: GALT stock exchange data.
Analyse the historical data and Galectin Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Galectin share price buy/sell indicators using real-time data (or discuss the Galectin (GALT) stock price today with other investors in the Galectin NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ GALT share price (ISIN: US3632252025) to enhance your trading decisions with our free investment tools and resources.
What Is the Galectin Therapeutics Inc Share Price Today?
The Galectin share price today is 3.990.
What Is the Stock Symbol for Galectin Therapeutics Inc
The stock symbol (or 'ticker') for Galectin Therapeutics Inc is "GALT."
What Stock Exchange Does Galectin Therapeutics Inc Trade On?
Galectin Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Galectin Therapeutics Inc a Good Stock to Buy?
Determining whether Galectin Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Galectin Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Galectin share price buy/sell indicators using real-time data (or discuss the Galectin (GALT) stock price today with other investors in the Galectin NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ GALT share price (ISIN: US3632252025) to enhance your trading decisions with our free investment tools and resources.
What Is the Galectin Therapeutics Inc Share Price Today?
The Galectin share price today is 3.990.
What Is the Stock Symbol for Galectin Therapeutics Inc
The stock symbol (or 'ticker') for Galectin Therapeutics Inc is "GALT."
What Stock Exchange Does Galectin Therapeutics Inc Trade On?
Galectin Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Galectin Therapeutics Inc a Good Stock to Buy?
Determining whether Galectin Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.530
4.130
52 wk Range
0.839
7.130
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.5304.130
52 wk Range
0.8397.130
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GALT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
11.000
Upside
+175.69%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Galectin Company Profile
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. Galectin Therapeutics Inc. has a collaborative joint venture co-owned by SBH Sciences, Inc. with Galectin Sciences, LLC for the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Compare GALT to Peers and Sector
Metrics to compare | GALT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGALTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.9x | −5.6x | −0.6x | |
PEG Ratio | −0.36 | 0.02 | 0.00 | |
Price/Book | −2.0x | 5.9x | 2.6x | |
Price / LTM Sales | - | 10.1x | 3.2x | |
Upside (Analyst Target) | 175.7% | 49.0% | 41.8% | |
Fair Value Upside | Unlock | −11.0% | 5.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 11.000
(+175.69% Upside)
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
-0.13 / -0.18
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Galectin (GALT) Share Price Today?
The live Galectin share price today is 3.990
What Stock Exchange Does Galectin (GALT) Trade On?
Galectin is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Galectin?
The stock symbol (also called a 'ticker') for Galectin is "GALT."
What Is the Current Galectin Market Cap?
As of today, Galectin market capitalisation is 257.25M.
What Is Galectin's (GALT) Earnings Per Share (TTM)?
The Galectin EPS is currently -0.59 (Trailing Twelve Months).
When Is the Next Galectin Earnings Date?
Galectin's next earnings report will be released on 26 Mar 2026.
Is GALT a Buy or Sell From a Technical Analyst Perspective?
Based on today's Galectin moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Galectin Stock Split?
Galectin has split 1 times. (See the GALT stock split history page for full effective split date and price information.)
How Many Employees Does Galectin Have?
Galectin has 15 employees.
What is the current trading status of Galectin (GALT)?
As of 24 Dec 2025, Galectin (GALT) is trading at a price of 3.990, with a previous close of 3.990. The stock has fluctuated within a day range of 3.530 to 4.130, while its 52-week range spans from 0.839 to 7.130.
What Is Galectin (GALT) Price Target According to Analysts?
The average 12-month price target for Galectin is USD11, with a high estimate of USD11 and a low estimate of USD11. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +175.69% Upside potential.
What Is the GALT After Hours Price?
GALT's last after hours stock price is 4.130, the stock has decreased by 0.140, or 3.510%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.